Quad screen

Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Definition

By Mayo Clinic staff

The quad screen is a prenatal test that measures levels of four substances in a pregnant woman's blood:

  • Alpha-fetoprotein (AFP), a protein produced by the baby's liver
  • Human chorionic gonadotropin (HCG), a hormone produced by the placenta
  • Estriol, another pregnancy-related hormone
  • Inhibin A, another pregnancy-related protein

Typically, the quad screen is done between weeks 15 and 20 of pregnancy. Results of the quad screen indicate your risk of carrying a baby who has certain developmental or chromosomal conditions, such as spina bifida or Down syndrome.

If your risk level is low, the quad screen can offer reassurance of a healthy pregnancy. If your risk level is moderate or high, you may choose to follow the quad screen with more invasive diagnostic testing — such as amniocentesis — to determine whether the baby actually has Down syndrome or other developmental or chromosomal conditions.

The quad screen is also known by various other names, including the quad marker screen, four-marker screen, multiple marker screen and maternal serum marker.

MY00127

July 2, 2008

© 1998-2009 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Reliable tools for healthier lives," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Text Size: smaller largerlarger